The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PI-REAL: A study of informed consent (IC) communication in real-time during phase I clinical trial encounters.
 
Manish Sharma
No Relationships to Disclose
 
Fay J. Hlubocky
Speakers' Bureau - Lilly
 
Mark J. Ratain
Stock and Other Ownership Interests - AspenBio Pharma; Biscayne Pharmaceuticals
Consulting or Advisory Role - AbbVie; Agios; Biscayne Pharmaceuticals; Cantex Pharmaceuticals; Cerulean Pharma; Cyclacel; Daiichi Sankyo; EMD Serono; Genentech/Roche; Kinex; Onconova Therapeutics; Sanofi; Shionogi; XSpray Microparticles AB
Research Funding - Bristol-Myers Squibb (Inst); Dicerna (Inst); OncoTherapy Science (Inst); PharmaMar (Inst)
Patents, Royalties, Other Intellectual Property - pending patent related to a genomic prescribing system; pending patent related to a genomic prescribing system (Inst); royalties related to UGT1A1 genotyping for irinotecan; royalties related to UGT1A1 genotyping for irinotecan (Inst)
Expert Testimony - Apotex; Fresenius Kabi; Mylan; Teva
 
Mark Siegler
No Relationships to Disclose
 
Christopher Daugherty
No Relationships to Disclose